OTHER NEWS - Dec. 18, 1992
From Times Staff and Wire Reports
Bolar Pharmaceutical Faces Price-Fixing Charges: A federal grand jury in Baltimore has indicted Bolar Pharmaceutical Co. and its president, Lawrence Raisfeld, on charges of conspiring to fix the price of a generic high blood-pressure medicine, the Justice Department said. According to the one-count indictment, Bolar Pharmaceutical and Raisfeld conspired with Vitarine Pharmaceuticals Inc. of Springfield Gardens, N.Y., and its president to set a range of prices at which the two companies would sell the drug Dyazide to various customers, the government said.
